Technical analysis of Baxter International Inc. (BAX): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Baxter International Inc., operating globally via its subsidiaries, is a leading developer and provider of a wide spectrum of healthcare products. The company's comprehensive portfolio includes various dialysis treatments, such as peritoneal and hemodialysis, along with related therapies and services. It also specializes in intravenous (IV) therapies, infusion pumps, administration sets, and devices for drug reconstitution.
Price Performance
| 1 month | -9.29% |
| 3 months | +18.30% |
| Year-to-date | +23.13% |
| 1 year | +1.42% |
| 3 years | -39.25% |
52-Week Range
| 52-week High | $30.00 |
| 52-week Low | $15.73 |
| Avg Volume (90d) | 6.5M |
Technical Indicators
| SMA 50 | $24.98 |
| SMA 200 | $20.55 |
| Beta | 0.62 |
| 30-day Volatility (annualised) | 24.1% |
| Price vs SMA 50 | -5.8% |
| Price vs SMA 200 | +14.5% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $18.47 | |
| 2025-11 | $18.74 | +1.5% |
| 2025-12 | $19.11 | +2.0% |
| 2026-01 | $20.07 | +5.0% |
| 2026-02 | $20.37 | +1.5% |
| 2026-03 | $16.80 | -17.5% |
| 2026-04 | $17.58 | +4.6% |
| 2026-05 | $18.78 | +6.8% |
| 2026-06 | $21.32 | +13.5% |
| 2026-07 | $26.16 | +22.7% |
| 2026-08 | $26.00 | -0.6% |
| 2026-09 | $23.53 | -9.5% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-15 | | |
| 2026-09-15 | | |
| 2026-09-15 | $0.05 | $88M |
| 2026-09-15 | | |
| 2026-09-15 | $0.14 | $2.28B |
| 2026-09-15 | | |
Price
| Price | $23.53 |
| Market Cap | $12.2B |
| Exchange | NYSE |
| Country | US |
Valuation Ratios
| Price / Book | 1.96 |
| EV / EBITDA | 23.29 |
| Dividend Yield | 0.17% |
Financial Health
| Debt / Equity | 1.56 |
| Current Ratio | 1.95 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 2.12 |